Prevalence of Antimicrobial Resistance in Select Bacteria From Retail Seafood-United States, 2019
- PMID: 35814688
- PMCID: PMC9262255
- DOI: 10.3389/fmicb.2022.928509
Prevalence of Antimicrobial Resistance in Select Bacteria From Retail Seafood-United States, 2019
Abstract
In 2019, the United States National Antimicrobial Resistance Monitoring System (NARMS) surveyed raw salmon, shrimp, and tilapia from retail grocery outlets in eight states to assess the prevalence of bacterial contamination and antimicrobial resistance (AMR) in the isolates. Prevalence of the targeted bacterial genera ranged among the commodities: Salmonella (0%-0.4%), Aeromonas (19%-26%), Vibrio (7%-43%), Pseudomonas aeruginosa (0.8%-2.3%), Staphylococcus (23%-30%), and Enterococcus (39%-66%). Shrimp had the highest odds (OR: 2.8, CI: 2.0-3.9) of being contaminated with at least one species of these bacteria, as were seafood sourced from Asia vs. North America (OR: 2.7; CI: 1.8-4.7) and Latin America and the Caribbean vs. North America (OR: 1.6; CI: 1.1-2.3) and seafood sold at the counter vs. sold frozen (OR: 2.1; CI: 1.6-2.9). Isolates exhibited pan-susceptibility (Salmonella and P. aeruginosa) or low prevalence of resistance (<10%) to most antimicrobials tested, with few exceptions. Seafood marketed as farm-raised had lower odds of contamination with antimicrobial resistant bacteria compared to wild-caught seafood (OR: 0.4, CI: 0.2-0.7). Antimicrobial resistance genes (ARGs) were detected for various classes of medically important antimicrobials. Clinically relevant ARGs included carbapenemases (bla IMI-2, bla NDM-1) and extended spectrum β-lactamases (ESBLs; bla CTX-M-55). This population-scale study of AMR in seafood sold in the United States provided the basis for NARMS seafood monitoring, which began in 2020.
Keywords: National Antimicrobial Resistance Monitoring System; United States; antimicrobial resistance; retail food; seafood.
Copyright © 2022 Tate, Ayers, Nyirabahizi, Li, Borenstein, Young, Rice-Trujillo, Saint Fleurant, Bodeis-Jones, Li, Tobin-D’Angelo, Volkova, Hardy, Mingle, M’ikanatha, Ruesch, Whitehouse, Tyson, Strain and McDermott.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Clinical and Laboratory Standards Institute (2016). Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria: Third edition. CLSI Document M45-Ed3. Wayne, PA. Clinical and Laboratory Standards Institute. - PubMed
-
- Clinical and Laboratory Standards Institute (2019). Performance Standards for Antimicrobial Susceptibility Testing: Thirtieth Edition. CLSI Document M100-Ed30. (Wayne, PA: ). Clinical and Laboratory Standards Institute.
